ClinicalTrials.Veeva

Menu

Construction of Early Warning Model for the New Psychoactive Substances Using in Adolescents

W

Wei XIA, PhD

Status

Not yet enrolling

Conditions

Drug Addiction

Treatments

Other: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT05958641
202310893

Details and patient eligibility

About

Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model of the New Psychoactive Substances (NPS) using for adolescents aged 14-35 years old. This study intends to obtain the data related to the behavioral expression of addiction susceptibility genes, adverse childhood experience, cognition, resistance and the use of NPS in adolescents by questionnaire survey (sample size: 200), and then use logistic regression and machine learning to construct an early warning model.

Full description

Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model on the use of the New Psychoactive Substances using for adolescents aged 14-35 years old. This study intends to conduct a questionnaire survey (sample size 200) to obtain data related to the behavioral expression of addiction susceptibility genes, childhood adversity experience, cognition, resistance and the use of NPS in adolescents from different regions and different populations. Through data analysis, this study aims to get the weight of different risk factors on NPS use, and then use logistic regression and machine learning to construct an early warning model, so as to screen out high-risk groups. At the same time, the expert group was consulted to establish a risk early warning system to provide a basis for intervention.

Enrollment

200 estimated patients

Sex

All

Ages

14 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adolescents aged 14-35 (including 14,35 years old)
  • Agree to participate in the studies

Exclusion criteria

  • Be diagnosed with psychological or mental illness
  • People that are unconscious, emotionally unstable, or unable to communicate normally
  • Patients with severe diseases

Trial design

200 participants in 1 patient group

Investigation Team
Description:
Questionnaires assessed adolescents aged 14-35 years old (including 14,25 years old) who agreed to participate in the study
Treatment:
Other: Questionnaires

Trial contacts and locations

1

Loading...

Central trial contact

Wei Xia, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems